Beth

Press Release

Overall global risk remains flat in Q1 2018

According to the latest results from the ‘Country Risk Index’ (GCRI) compiled by GlobalData, a leading data and analytics company, the overall global risk score remained flat at 40.1 out of 100 in Q1 2018 – unchanged from Q3 2017, following a reduction from 40.4 in Q2 2017. The company’s index is a unique country […]

Retail

Tesco’s new discount chain is a risky response to Aldi and Lidl

Following speculation that Tesco is to launch a new discount fascia in the UK to compete with Aldi and Lidl, Thomas Brereton, Retail Analyst at GlobalData, a leading data and analytics company, offers his view on the fascia’s potential: “The possibility of Tesco opening a discount fascia in a bid to neutralize the growing threat […]

Press Release

Despite strong growth, Domino’s remains at risk from delivery aggregators

Following the release of Domino’s Pizza Q2 2018 results, Peter Ramshaw, Foodservice Analyst at GlobalData, a leading data and analytics company, comments: “Domino’s second quarter 2018 financial results saw the company record its 98th consecutive quarter of positive international same store sales growth and the 20th consecutive quarter of positive domestic same store sales growth. […]

Technology

New players in the MVNO segment to boost competition in the Peruvian mobile market

Over the last few years, the Peruvian telecoms regulator OSIPTEL has been introducing a series of measures to boost competition in the mobile communications market, including the ongoing reduction of mobile termination rates (MTR) and the introduction specific regulation aimed at facilitating the entry of mobile virtual network operator (MVNOs) in the market, according to […]

Press Release

The ‘Biosimilar Action Plan’ is another FDA move designed to chase value based pricing

On Wednesday (18 July) the FDA unveiled the ‘Biosimilar Action Plan’ (BAP), which aims to promote the development and accessibility of biosimilars in the US healthcare market. Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what this means for the price of branded biologic molecules: “We believe […]

Press Release

J&J’s HIV therapeutic Symtuza on track for US launch in 2018 after FDA approval

Following the news (Tuesday 17th July) that J&J’s HIV therapeutic, Symtuza, has been granted marketing approval by the FDA, Tom Moore, Senior Healthcare Analyst at GlobalData, a leading data and analytics company, offers his view: “This news puts J&J’s Symtuza on track to launch in the US later this year, where it is predicted to […]

Press Release

Personalized medication is becoming an increasing possibility for patients, due to the use of newly developed algorithms

A long sought after objective of healthcare is to ensure that each patient receives tailored treatment for their medical situation; and now, with the use of big data and newly developed algorithms this is starting to look like a genuine possibility for patients, says GlobalData, a leading data and analytics company. A study conducted at […]

Technology

Walmart’s move to Microsoft Azure more about AI dominance than cloud reach

Following the news (Monday, 16 July) that Walmart had entered into a five year strategic partnership with Microsoft that would see the retail giant shift its business to both Microsoft Azure and Microsoft 365, Brad Shimmin, Technology Analyst at GlobalData, a leading data and analytics company, offers his view on the real drivers underscoring this […]

Press Release

Positive Phase III results in high-risk patients expected to support FDA review process for Roche’s Xofluza

Following yesterday’s news (Tuesday 17th July) that Roche has announced positive top-line results from its Phase III trial for influenza drug, Xofluza, Tom Moore, Senior Healthcare Analyst at GlobalData, a leading data and analytics company, offers his view: “Xofluza is forecast to reach annual sales of $600m by 2024. Although the drug is on track […]

Press Release

Global venture capital funding grows in the higher value and early stage bands at Q1 2018

Global venture capital investments have continued to pour into higher value bands, marking a second straight quarterly rise for the segment in Q1 2018, according to GlobalData, a leading data and analytics company. The >$500m-$1000m band witnessed a significant 191% rise from an average of 2.75 investments registered in the previous four quarters to 8 […]

Press Release

Amazon whole foods sector could play role in the prevention of chronic diseases

Chronic diseases, such as heart disease, stroke, type 2 diabetes (T2D), cancer and chronic respiratory diseases, are the most common and most costly health problems, yet they are largely preventable by lifestyle changes, says GlobalData, a leading data and analytics company. The company’s latest report: ‘PharmaPoint: Type 2 Diabetes’, reveals that 26.5 million people were […]

Press Release

Amazon’s dive into healthcare could benefit patients requiring frequent medical products

Since Amazon took its strategic move of plunging into healthcare, its plans are progressively unfolding, driving down market value of many of the industry’s biggest retail pharmacies including Walgreens, CVS and Rite Aid, says GlobalData, a leading data and analytics company. The e-commerce giant, who was already selling medical supplies and equipment, and whole foods, […]

Press Release

Sweden’s cross-border merger and acquisitions activity continued to grow at a rapid pace in 2017

Global inbound and outbound merger and acquisitions (M&A) activity in 2017 was characterised by the continued dominance of the US in both volume and value and Sweden’s emergence as a leading M&A nation in percentage volume growth terms, according to GlobalData, a leading data and analytics company. Outbound M&A is where a domestic company merges […]

Press Release

Top 25 global consumer packaged goods companies by market cap Q1 2018

The performance highlights of the Top 25 publicly traded global consumer packaged goods companies by Market Cap (Mcap) have been analysed in the latest research from GlobalData, a leading data and analytics company. The completed day vs day (31 Mar 2018 vs 31 Dec 2017) analysis reveals a number of interesting insights. The list of […]

Press Release

Recent European Medicines Agency survey findings on pharma brexit preparedness are supported by GlobalData’s own survey findings

Following today’s news (Wednesday 11th July) that a European Medicines Agency (EMA) survey has identified gaps in the pharmaceutical industry’s preparedness for Brexit, Tom Moore, Senior Healthcare Analyst at GlobalData, a leading data and analytics company, offers his view based on GlobalData’s own findings: “In results from a survey carried out by the EMA, announced […]

Press Release

Merck to expand Keyruda’s indication list as they further cement themselves as a key player in cancer therapeutics

Following today’s news (Wednesday 11 July) that the FDA have accepted Merck’s supplementary biologic license application (sBLA) for monoclonal antibody Keytruda (pembrolizumab) to be used in patients suffering from advanced hepatocellular carcinoma, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what the next steps are: “Hepatocellular carcinoma […]

Press Release

UK SIPP market to grow by £1.9bn yearly to 2020 despite rising customer complaints

The UK Self-Invested Personal Pension (SIPP) market is flourishing, with growth continuing throughout 2017. However, there has been a rise in complaints about the product mainly due to diligence failings, according to GlobalData, a leading data and analytics company. GlobalData’s latest report: ‘UK Self-Invested Personal Pensions 2018’ highlights that the UK SIPP market was worth […]

Press Release

GlobalData adds BioPharm Insight’s investigative journalist team to Healthcare division

Leading data and analytics company GlobalData is pleased to announce the incorporation of BioPharm Insight’s investigative journalist content into its Healthcare offering. The consolidation follows on from GlobalData’s acquisition of BioPharm Insight as part of the Infinata suite of products in April 2017. The journalist team is based in London and New York and consists […]

Press Release

NICE rejection of Roche’s Ocrevus could signal more value based assessments by the regulator

The National Institute for Health and Care Excellence (NICE) has issued a negative appraisal consultation document (ACD) for Roche’s OCREVUS®▼ (ocrelizumab) in primary progressive multiple sclerosis (PPMS)– citing the high annual cost of therapy as an unacceptable burden for the NHS to bear. Despite the fact that the drug was approved by the FDA in […]

Press Release

Insurance in the gig economy is a growing market and insurers must capitalize on the opportunity

The UK insurance market has seen the emergence of the gig economy as an opportunity not only for employment purposes but also as a new and growing market. With 2.8 million individuals working within the gig economy, those who are quick to scale in the market will undoubtedly reap the benefits, according to GlobalData, a […]

Prev 1 … 90 91 92 93 Next

Overall global risk remains flat in Q1 2018

Tesco’s new discount chain is a risky response to Aldi and Lidl

Despite strong growth, Domino’s remains at risk from delivery aggregators

New players in the MVNO segment to boost competition in the Peruvian mobile market

The ‘Biosimilar Action Plan’ is another FDA move designed to chase value based pricing

J&J’s HIV therapeutic Symtuza on track for US launch in 2018 after FDA approval

Personalized medication is becoming an increasing possibility for patients, due to the use of newly developed algorithms

Walmart’s move to Microsoft Azure more about AI dominance than cloud reach

Positive Phase III results in high-risk patients expected to support FDA review process for Roche’s Xofluza

Global venture capital funding grows in the higher value and early stage bands at Q1 2018

Amazon whole foods sector could play role in the prevention of chronic diseases

Amazon’s dive into healthcare could benefit patients requiring frequent medical products

Sweden’s cross-border merger and acquisitions activity continued to grow at a rapid pace in 2017

Top 25 global consumer packaged goods companies by market cap Q1 2018

Recent European Medicines Agency survey findings on pharma brexit preparedness are supported by GlobalData’s own survey findings

Merck to expand Keyruda’s indication list as they further cement themselves as a key player in cancer therapeutics

UK SIPP market to grow by £1.9bn yearly to 2020 despite rising customer complaints

GlobalData adds BioPharm Insight’s investigative journalist team to Healthcare division

NICE rejection of Roche’s Ocrevus could signal more value based assessments by the regulator

Insurance in the gig economy is a growing market and insurers must capitalize on the opportunity

Browse

Company information